Detalles de la búsqueda
1.
The physiological interactome of TCR-like antibody therapeutics in human tissues.
Nat Commun
; 15(1): 3271, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627373
2.
A Novel Approach for Quantifying the Pharmacological Activity of T-Cell Engagers Utilizing In Vitro Time Course Experiments and Streamlined Data Analysis.
AAPS J
; 24(1): 7, 2021 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34862519
3.
Pharmacokinetics and Pharmacodynamics of T-Cell Bispecifics in the Tumour Interstitial Fluid.
Pharmaceutics
; 13(12)2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34959386
4.
Predicting Tumor Killing and T-Cell Activation by T-Cell Bispecific Antibodies as a Function of Target Expression: Combining In Vitro Experiments with Systems Modeling.
Mol Cancer Ther
; 20(2): 357-366, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33298591
5.
Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies.
Elife
; 102021 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34378534
6.
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer.
MAbs
; 8(4): 811-27, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26984378
7.
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Clin Cancer Res
; 22(13): 3286-97, 2016 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26861458
8.
Preclinical activity of the type II CD20 antibody GA101 (obinutuzumab) compared with rituximab and ofatumumab in vitro and in xenograft models.
Mol Cancer Ther
; 12(10): 2031-42, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23873847
Resultados
1 -
8
de 8
1
Próxima >
>>